MYM Announces Amendment to Loan Agreement

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.


Vancouver, British Columbia - TheNewswire - January 14, 2021 - MYM Nutraceuticals Inc., (CSE:MYM) (CNSX:MYM.CN) (OTC:MYMMF) (“MYM” or the “Company”) announces that it has agreed to amend the terms of the Loan Agreement (the “Loan Agreement”) dated July 31, 2020 with 1909203 Ontario Inc (the “Lender”).

The Lender and MYM have agreed to enter into an Amendment to the Loan Agreement (the “Amendment”) to defer all interest payable under the Loan Agreement to be due and payable on the maturity date as defined in the Loan Agreement.  As consideration for the Amendment, the Company will issue 1,000,000 purchase warrants (the “Warrants”) to the Lender. 

Each Warrant will entitle the holder to purchase one Share (a "Warrant Share") for a period of thirty-six (36) months from the issue date at a price of $0.095 per Warrant Share. The Warrants are subject to an acceleration provision that allows the Company to give notice of an earlier expiry date if the Company’s weighted average share price on the CSE (or such other stock exchange the Company may be trading on) is equal or greater than $0.19 for a period of 10 consecutive trading days.

As certain insiders participated in the Transaction, it is considered to be a “related party transaction” as defined under Multilateral Instrument 61-101 (“MI 61-101”).  The transaction is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of the securities to be distributed in the Transaction in so far as the Transaction involves the insiders, exceeds 25% of the Company’s market capitalization.

The Transaction is subject to the approval of the Canadian Securities Exchange (the “CSE”).

About MYM Nutraceuticals Inc.

MYM is a Canadian cultivator, processor, and distributor of premium cannabis via its two wholly owned subsidiaries – SublimeCulture Inc., in Laval, QC and Highland Grow Inc., in Antigonish, NS. MYM shares trade in Canada, Germany and the United States under the following symbols: (CSE: MYM) (OTC: MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

Michael Wiener, CEO
MYM Nutraceuticals Inc.

Investor Relations

[email protected]

Keep up to date with MYM on our social media channels:






Copyright (c) 2021 TheNewswire - All rights reserved.